1. Home
  2. XP vs LNTH Comparison

XP vs LNTH Comparison

Compare XP & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XP Inc.

XP

XP Inc.

HOLD

Current Price

$18.62

Market Cap

9.9B

Sector

Finance

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$93.95

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XP
LNTH
Founded
2001
1956
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
5.6B
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
XP
LNTH
Price
$18.62
$93.95
Analyst Decision
Strong Buy
Buy
Analyst Count
6
6
Target Price
$23.17
$87.00
AVG Volume (30 Days)
3.9M
751.2K
Earning Date
05-19-2026
05-07-2026
Dividend Yield
0.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.80
Revenue
N/A
$343,374,000.00
Revenue This Year
$19.00
N/A
Revenue Next Year
$13.64
$14.19
P/E Ratio
$11.42
$51.71
Revenue Growth
N/A
3.62
52 Week Low
$15.61
$47.27
52 Week High
$23.13
$94.86

Technical Indicators

Market Signals
Indicator
XP
LNTH
Relative Strength Index (RSI) 43.95 73.90
Support Level $18.50 $72.35
Resistance Level $20.29 N/A
Average True Range (ATR) 0.58 2.85
MACD -0.10 0.82
Stochastic Oscillator 10.73 87.33

Price Performance

Historical Comparison
XP
LNTH

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission. Geographically, the company derives maximum revenue from Brazil and also has its presence in other countries.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: